References
- Haleblian J. K. Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J. Pharm. Sci. 1975; 64: 1269–1288
- Haleblian J. K., McCrone W. Pharmaceutical applications of polymorphism. J. Pharm. Sci. 1969; 58: 911–929
- Zografi G. States of water associated with solids. Drug Dev. Ind. Pharm. 1988; 14: 1905–1926
- The United States Pharmacopeia. XXIII revision. United States Pharmacopeial Convention, Rockville, MD 1994
- Byrn S. R. Solid-state Chemistry of Drugs. Academic Press, New York, NY 1982
- Byrn S. R., Pfeiffer R., Ganey M., Hoiberg C., Poochikian G. Pharmaceutical solids: A strategic approach to regulatory considerations. Pharm. Res. 1995; 12: 945–954
- Topely B., Smith M. L. Kinetics of salt-hydrate dissociations: MnC2O4·2H2O = MnC2O4 + 2H2O. J. Chem. Soc. 1935; 321–325
- Gamer W. E. Kinetics of endothermic solid reactions. Chemistry of the Solid State, W. E. Garner. Academic Press, New York, NY 1955
- Lumpkin J. A., Perlmutter D. D. Thermal and water vapor effects on the rate of the dehydration reactions of barium chloride. Thermochim. Acta 1995; 249: 335–349
- Han J., Suryanarayanan R. Applications of pressure differential scanning calorimetry in the study of pharmaceutical hydrates. 1. carbamazepine dihydrate. Int. J. Pharm. 1997; 157: 209–218
- Khankari R. K., Grant D. J. W. Pharmaceutical hydrates. Thermochim. Acta 1995; 248: 61–79
- Kitaoka H., Ohya K., Hakusui H. Thermal dehydration of nafagrel hydrochloride hydrate at controlled water vapor partial pressures. Chem. Pharm. Bull. 1995; 43: 1744–1750
- Giesser U. J., Burger A. The effect of water vapor pressure on desolvation kinetics of caffeine 4/5-hydrate. Int. J. Pharm. 1995; 120: 83–93
- Ledwidge M. T., Corrigan O. I. Effects of environmental factors on the dehydration of diclofenac HEP dihydrate and theophylline monohydrate. Int. J. Pharm. 1997; 147: 41–49
- Lyakhov N. Z., Boldyrev V. V. Kinetics and mechanism of the dehydration of crystal hydrates. Russian Chem. Rev. 1972; 41: 919–928
- Budaveri S. The Merck Index12th ed. Merck and Co., Whitehouse Station, N.J. 1996; 290
- Lowes M. M. J., Caira M. R., Lotter A. P. J., Van Der Watt G. Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine. J. Pharm. Sci. 1987; 76: 744–752
- Pohlmann H., Guide C., Jahn R., Pfeifer S. Polymorphism, particle size, and blood concentrations of carbamazepine. Pharmazie 1975; 30: 709–711
- Umeda T., Ohnishi N., Yokoyama T., Kuroda K., Kuroda T., Tatsumi E., Matsuda Y. Kinetics of the thermal transition of carbamazepine polymorphic forms in the solid state. Yakugaku Zasshi 1984; 104: 786–792
- Dugué J., Céolin R., Rouland J. C., Lepage F. Polymorphism of carbamazepine: Solid-state studies on carbamazepine dihydrate. Pharm. Acta Helv. 1991; 66: 307–310
- Krahn F. U., Mielck J. B. Relations between several polymorphic forms and the dihydrate of carbamazepine. Pharm. Acta Helv. 1987; 62: 247–254
- Suryanarayanan R. Determination of the relative amounts of anhydrous carbamazepine (C15H12, N2O) and carbamazepine dihydrate (C15H12N2O·2 H2O) in a mixture by powder X-ray diffractometry. Pharm. Res. 1989; 6: 1017–1024
- McMahon L. E., Timmins P., Williams A. C., York P. Characterization of dihydrates prepared from carbamazepine polymorphs. J. Pharm. Sci. 1996; 85: 1064–1069
- Reboul J. P., Cristau B., Soyfer J. C., Astier J. P. 5H-Dibenz[b, f]azépinecarboxzmide-5 (Carbamazépine). Acta Crystallogr. 1981; B37: 1844–1848
- Himes V. L., Mighell A. D. W., De Camp H. Structure of carbamazepine: 5H-Dibenz[bf]azepine-5-car-boxamide. Acta Crystallogr. B 1981; 37: 2242–2245
- Ceolin R., Toscani S., Cardette M., Agafonov V. N., Dzyabchenko A. V., Bachet B. X-ray characterization of the triclinic polymorph of carbamazepine. J. Pharm. Sci. 1997; 86: 1062–1065
- Reck G., Dietz G. The order-disorder structure of carbamazepine dihydrate: SH-Dibenz[b, f]azepine-5-car-boxamide dihydrate, C15H12N2O·2 H2O. Cryst. Res. Technol. 1986; 21: 1463–1468
- Han J. Influence of environmental conditions on the dehydration of pharmaceutical hydrates. Ph.D. dissertation, University of Minnesota. 1998
- Du Pont Films Film Selector Guide—For DuPont Mylar® Polyester Film. Du Pont 1995
- Sharp J. H., Brindley G. W., Achar B. N. N. Numerical data for some commonly used solid state reaction equations. J. Am. Ceram. Soc. 1963; 52: 781–791
- Monkhouse D. C. L., Van Campen. Solid state reactions-Theoretical and experimental aspects. Drug Dev. Ind. Pharm. 1984; 10: 1175–1276
- Ahlneck C., Zografi G. The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int. J. Pharm. 1990; 62: 87–95
- Wheeler R. C., Frost G. B. A comparative study of the dehydration kinetics of several hydrated salts. Canad. J. Chem. 1955; 33: 546–561
- Avrami M. Kinetics of phase change: I. J. Chem. Phys. 1939; 7: 1103–1112
- Avrami M. Kinetics of phase change: KII. J. Chem. Phys. 1940; 8: 212–224
- Avrami M. Kinetics of phase change: III. J. Chem. Phys. 1941; 9: 177–184
- Andronis V., Yoshioka M., Zografi G. Effects of sorbed water on the crystallization of indomethacin from the amorphous state. J. Pharm. Sci. 1997; 86: 346–351
- Yoshioka M., Hancock B. C., Zografi G. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature. J. Pharm. Sci. 1994; 83: 1700–1705